ZUU-11787-51502 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-20
Registered in v-safe
2021-03-20
Dose 1 — Janssen/Johnson & Johnson
2021-03-20
Survey response — day 0, dose 1
MedDRA: No adverse event — Feeling: Poor · Site: Swelling · Fever · Chills, Muscle or body aches · Be unable to do your normal daily activities

Free text: No

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-03-20
Report sent to call center — day 0, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-03-21
Health check-in — days 1–6 daily, dose 1
Feeling: Fair · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-03-21
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-20	Janssen/Johnson & Johnson

Call center

Reported	Outcome	VAERS-related outcome
2021-03-20	priority 2/3
2021-03-21	priority 2/3

Free text

Release 6 — day 0, dose 1

2021-03-20

Systemic reaction (other): No

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	No adverse event	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release